SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 4.88 |
| Enterprise Value ($M) | 17.56 |
| Book Value ($M) | 15.42 |
| Book Value / Share | 26.05 |
| Price / Book | 0.32 |
| NCAV ($M) | -11.34 |
| NCAV / Share | -19.16 |
| Price / NCAV | -0.43 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.19 |
| Return on Assets (ROA) | -0.15 |
| Return on Equity (ROE) | -0.51 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.67 |
| Current Ratio | 0.67 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 3.34 |
| Assets | 30.10 |
| Liabilities | 14.68 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -16.84 |
| Net Income | -20.29 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -13.44 |
| Cash from Investing | -0.01 |
| Cash from Financing | 11.60 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Lincoln Park Capital Fund, LLC | 6.18 | -26.11 | |
| 13G/A | Lind Global Fund II LP | 5.30 | -38.94 | |
| 13G | Flynn James E | 7.59 | ||
| 13G | Duvvuri Krishna | 6.35 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 11,651,718 | 33,550,609 | 34.73 | |
| 26,483 | 120,073 | 22.06 | |
| 11,787 | 31,878 | 36.98 | |
| 14,515 | 59,929 | 24.22 | |
| 1,436 | 3,595 | 39.94 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| VTVT – vTv Therapeutics Inc. | VXRT – Vaxart, Inc. |
| VYNE – VYNE Therapeutics Inc. | XBIO – Xenetic Biosciences, Inc. |
| XCUR – Exicure, Inc. |
Financial data and stock pages provided by
Fintel.io